Page last updated: 2024-10-25

deferiprone and Central Nervous System Diseases

deferiprone has been researched along with Central Nervous System Diseases in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Treatment with DFP proved safe and well tolerated."1.51Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study. ( Abbruzzese, G; Cossu, G; Forni, GL; Marchese, R; Matta, G; Oppo, V; Pinto, V; Ruffinengo, U, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cossu, G1
Abbruzzese, G1
Forni, GL1
Matta, G1
Pinto, V1
Ruffinengo, U1
Oppo, V1
Marchese, R1

Other Studies

1 other study available for deferiprone and Central Nervous System Diseases

ArticleYear
Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019, Volume: 40, Issue:7

    Topics: Aged; Brain; Central Nervous System Diseases; Deferiprone; Follow-Up Studies; Hemosiderin; Humans; I

2019